Loading clinical trials...
Loading clinical trials...
Role of vaginal misoprostol prior to IUCD insertion in women who delivered only by elective caesarean section.
Misoprostol ( 400mcg ) vaginally administrated 3 hours prior to IUCD insertion increases the ease and success of insertion and decrease associated pain among women who had delivered only by elective caesarean section.
Age
20 - 40 years
Sex
FEMALE
Healthy Volunteers
Yes
Enas Mahmoud
Cairo, Egypt
Start Date
July 1, 2018
Primary Completion Date
July 1, 2019
Completion Date
December 1, 2019
Last Updated
May 7, 2019
210
ESTIMATED participants
misoprostol
DRUG
Placebo
DRUG
Lead Sponsor
Ain Shams University
NCT05875571
NCT05594108
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03828760